Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.95% | -3.00% | -4.08% | -10.47% | -15.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.95% | -3.00% | -4.08% | -10.47% | -15.63% |
| Cost of Revenue | -12.34% | -8.29% | 13.38% | 8.53% | -6.00% |
| Gross Profit | -4.77% | 0.39% | -12.84% | -19.25% | -21.44% |
| SG&A Expenses | -29.15% | -18.10% | -15.70% | -1.97% | -6.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.97% | -15.50% | -8.97% | 1.14% | -5.04% |
| Operating Income | 53.88% | 47.23% | 21.61% | -41.25% | -17.89% |
| Income Before Tax | 45.30% | 52.08% | 6.59% | -585.83% | -29.97% |
| Income Tax Expenses | -7.55% | 2.30% | 118.87% | -24.24% | 102.34% |
| Earnings from Continuing Operations | 45.03% | 51.59% | -1.05% | -546.32% | -114.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 57.14% | 82.35% | -54.35% | 20.00% | -71.43% |
| Net Income | 45.22% | 51.83% | -1.60% | -559.56% | -117.51% |
| EBIT | 53.88% | 47.23% | 21.61% | -41.25% | -17.89% |
| EBITDA | 54.89% | 48.33% | 21.57% | -42.77% | -19.42% |
| EPS Basic | 53.41% | 56.33% | -1.65% | -559.23% | -117.18% |
| Normalized Basic EPS | 53.76% | 36.24% | 5.97% | -79.72% | -31.27% |
| EPS Diluted | 53.41% | 56.33% | -1.65% | -559.23% | -117.18% |
| Normalized Diluted EPS | 53.76% | 36.24% | 5.97% | -79.72% | -31.27% |
| Average Basic Shares Outstanding | 17.56% | 10.31% | 0.01% | 0.12% | 0.13% |
| Average Diluted Shares Outstanding | 17.56% | 10.31% | 0.01% | 0.12% | 0.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |